Illumina Inc (ILMN) - Total Assets
Based on the latest financial reports, Illumina Inc (ILMN) holds total assets worth $6.64 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ILMN operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Illumina Inc - Total Assets Trend (1999–2025)
This chart illustrates how Illumina Inc's total assets have evolved over time, based on quarterly financial data. See net assets of Illumina Inc for net asset value and shareholders' equity analysis.
Illumina Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Illumina Inc's total assets of $6.64 Billion consist of 49.5% current assets and 50.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.42 Billion | 21.3% |
| Accounts Receivable | $854.00 Million | 12.9% |
| Inventory | $564.00 Million | 8.5% |
| Property, Plant & Equipment | $1.13 Billion | 17.0% |
| Intangible Assets | $210.00 Million | 3.2% |
| Goodwill | $1.11 Billion | 16.8% |
Asset Composition Trend (1999–2025)
This chart illustrates how Illumina Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ILMN market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Illumina Inc's current assets represent 49.5% of total assets in 2025, a decrease from 98.8% in 1999.
- Cash Position: Cash and equivalents constituted 21.3% of total assets in 2025, down from 62.4% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is cash and equivalents at 21.3% of total assets.
Illumina Inc Competitors by Total Assets
Key competitors of Illumina Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Thyrocare Technologies Limited
NSE:THYROCARE
|
India | Rs7.47 Billion |
|
Shanghai Runda Med Tech Co
SHG:603108
|
China | CN¥13.79 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193
|
China | CN¥984.02 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
BioPorto
CO:BIOPOR
|
Denmark | Dkr93.18 Million |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
Illumina Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.08 | 1.78 | 4.45 |
| Quick Ratio | 1.72 | 1.42 | 4.16 |
| Cash Ratio | 0.89 | 0.73 | 0.00 |
| Working Capital | $1.70 Billion | $1.20 Billion | $4.37 Billion |
Illumina Inc - Advanced Valuation Insights
This section examines the relationship between Illumina Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.58 |
| Latest Market Cap to Assets Ratio | 2.76 |
| Asset Growth Rate (YoY) | 5.4% |
| Total Assets | $6.64 Billion |
| Market Capitalization | $18.34 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Illumina Inc's assets at a significant premium (2.76x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Illumina Inc's assets grew by 5.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Illumina Inc (1999–2025)
The table below shows the annual total assets of Illumina Inc from 1999 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $6.64 Billion | +5.41% |
| 2024-12-31 | $6.30 Billion | -37.66% |
| 2023-12-31 | $10.11 Billion | -17.47% |
| 2022-12-31 | $12.25 Billion | -19.48% |
| 2021-12-31 | $15.22 Billion | +100.62% |
| 2020-12-31 | $7.58 Billion | +3.68% |
| 2019-12-31 | $7.32 Billion | +5.13% |
| 2018-12-31 | $6.96 Billion | +32.38% |
| 2017-12-31 | $5.26 Billion | +22.81% |
| 2016-12-31 | $4.28 Billion | +16.08% |
| 2015-12-31 | $3.69 Billion | +10.50% |
| 2014-12-31 | $3.34 Billion | +10.55% |
| 2013-12-31 | $3.02 Billion | +17.65% |
| 2012-12-31 | $2.57 Billion | +16.86% |
| 2011-12-31 | $2.20 Billion | +19.40% |
| 2010-12-31 | $1.84 Billion | +28.61% |
| 2009-12-31 | $1.43 Billion | +3.84% |
| 2008-12-31 | $1.38 Billion | +39.42% |
| 2007-12-31 | $987.73 Million | +228.60% |
| 2006-12-31 | $300.58 Million | +198.76% |
| 2005-12-31 | $100.61 Million | +6.01% |
| 2004-12-31 | $94.91 Million | -4.36% |
| 2003-12-31 | $99.23 Million | -18.60% |
| 2002-12-31 | $121.91 Million | -0.46% |
| 2001-12-31 | $122.47 Million | -7.78% |
| 2000-12-31 | $132.79 Million | +291.78% |
| 1999-12-31 | $33.89 Million | -- |
About Illumina Inc
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and … Read more